Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Derivatives of 4-demethylpenclomedine useful as antitumor agents

Sep. 18, 2000

Stem cell transplant benefits some renal cell carcinoma patients

Sep. 18, 2000

OSI's ERF receptor inhibitor continues to demonstrate anticancer activity and good safety

Sep. 15, 2000

Antibody and protein therapeutics for breast cancer sought by Eos and Biogen collaboration

Sep. 15, 2000

Oleander extract selectively kills human cancer cells via an effect on TRF2

Sep. 15, 2000

Protein-peptide fusion stimulates anticancer activity without adjuvant

Sep. 15, 2000

Exclusive access to technology for potential cancer vaccine granted to Viragen

Sep. 14, 2000

Clinical trials with polymer platinate AP-5280 to begin

Sep. 14, 2000

New leads in the search for next-generation microtubule-directed taxoids

Sep. 14, 2000

Telomerase immunization induces antitumor response

Sep. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...